BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12145904)

  • 1. [Hyperstosis in patients with intracranial meningioma--secondary changes in tumor invasion].
    Kvasha MS
    Lik Sprava; 2002; (3-4):90-3. PubMed ID: 12145904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperostosis associated with meningioma of the cranial base: secondary changes or tumor invasion.
    Pieper DR; Al-Mefty O; Hanada Y; Buechner D
    Neurosurgery; 1999 Apr; 44(4):742-6; discussion 746-7. PubMed ID: 10201298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between sex hormone receptors and peritumoral edema in intracranial meningiomas.
    Maiuri F; Montagnani S; Iaconetta G; Gallicchio B; Bernardo A; Signorelli F
    J Neurosurg Sci; 1994 Mar; 38(1):29-33. PubMed ID: 7965139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of bone-invasive, hyperostotic sphenoid wing meningiomas.
    Bikmaz K; Mrak R; Al-Mefty O
    J Neurosurg; 2007 Nov; 107(5):905-12. PubMed ID: 17977259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of progesterone and estrogen receptors in meningiomas.
    Omulecka A; Papierz W; Nawrocka-Kunecka A; Lewy-Trenda I
    Folia Neuropathol; 2006; 44(2):111-5. PubMed ID: 16823693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does bony hyperostosis in intracranial meningioma signify tumor invasion? A radio-pathologic study.
    Goyal N; Kakkar A; Sarkar C; Agrawal D
    Neurol India; 2012; 60(1):50-4. PubMed ID: 22406780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible role of matrix metalloproteinases (MMPs) in hyperostosis of intracranial meningiomas.
    Pei J; Jung S; Jin SG; Moon KS; Wen M; Li SY; Jang WY; Ryu HH; Lee KH; Kim IY; Jung TY
    Acta Neurochir (Wien); 2012 Apr; 154(4):611-20; discussion 620. PubMed ID: 22327326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression.
    Abdelzaher E; El-Gendi SM; Yehya A; Gowil AG
    Br J Neurosurg; 2011 Dec; 25(6):707-13. PubMed ID: 20979437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of progesterone and estrogen receptor expression in 15 meningiomas of dogs and cats.
    Adamo PF; Cantile C; Steinberg H
    Am J Vet Res; 2003 Oct; 64(10):1310-8. PubMed ID: 14596471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen and progesterone receptors in meningiomas.
    Maiuri F; Montagnani S; Gallicchio B
    Surg Neurol; 1986 Nov; 26(5):435-40. PubMed ID: 3764648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of steroid receptors and growth factors expression with peritumoral edema accompanying cerebral neoplasms].
    Och W; Smółka M; Mariak Z; Koziorowski M
    Neurol Neurochir Pol; 2000; 34(1):91-101. PubMed ID: 10849907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical expression of progesterone receptor in relationship with histological grade and risk of relapses in intracranial meningiomas].
    Hernández Faraco A; Céspedes G; Trejo E
    Neurologia; 2009 May; 24(4):235-44. PubMed ID: 19603293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status of Ki-67, estrogen and progesterone receptors in various subtypes of intracranial meningiomas.
    Fakhrjou A; Meshkini A; Shadrvan S
    Pak J Biol Sci; 2012 Jun; 15(11):530-5. PubMed ID: 24191627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between sex hormone binding and peritumoral edema in intracranial meningiomas.
    Benzel EC; Gelder FB
    Neurosurgery; 1988 Aug; 23(2):169-74. PubMed ID: 3185875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of aromatase and estrogen, androgen and progesterone receptors in normal and neoplastic human meningeal cells.
    Leães CG; Meurer RT; Coutinho LB; Ferreira NP; Pereira-Lima JF; da Costa Oliveira M
    Neuropathology; 2010 Feb; 30(1):44-9. PubMed ID: 19703265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and immunohistochemical expression levels of androgen, estrogen, progesterone and Ki-67 receptors in relationship with gross-total resected meningiomas relapse.
    Tao Y; Liang G; Li Z; Wang Y; Wu A; Wang H; Lu Y; Liu Z; Hu G
    Br J Neurosurg; 2012 Oct; 26(5):700-4. PubMed ID: 22616825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen- and progesterone-receptors in meningiomas. Review article.
    Goffin J
    Clin Neurol Neurosurg; 1986; 88(3):169-75. PubMed ID: 3536253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Behavior of estrogen and progesterone receptors in intracranial meningioma].
    Oddi G; Rebeck L; Bruni P
    Pathologica; 1989; 81(1075):515-22. PubMed ID: 2641153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin receptor is expressed in meningiomas and lower levels are associated with tumour recurrence.
    Küster O; Simon P; Mittelbronn M; Tabatabai G; Hermann C; Strik H; Dietz K; Roser F; Meyermann R; Schittenhelm J
    Neuropathol Appl Neurobiol; 2009 Dec; 35(6):555-65. PubMed ID: 19298633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An audit of immunohistochemical marker patterns in meningioma.
    Baxter DS; Orrego A; Rosenfeld JV; Mathiesen T
    J Clin Neurosci; 2014 Mar; 21(3):421-6. PubMed ID: 24231566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.